QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2022    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study 期刊论文 CANCER, 2022 作者:  Gu, Jionghui;  Tong, Tong;  Xu, Dong;  Cheng, Fang;  Fang, Chengyu 收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23 breast cancer  deep learning  lymph node metastasis  neoadjuvant chemotherapy  pathologic complete response  treatment decision  ultrasonography   Even-denominator fractional quantum Hall state in bilayer graphene 期刊论文 ACTA PHYSICA SINICA, 2022, 卷号: 71 作者:  Li Qing-Xin;  Huang Yan;  Chen Yi-Wei;  Zhu Yu-Jian;  Zhu Wang 收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23 graphene  fractional quantum Hall effect  topological phase   Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li 收藏  |  浏览/下载：29/0  |  提交时间：2022/12/22 A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling 收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23 Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Jin, Jing;  Tang, Yuan;  Hu, Chen;  Jiang, Li-Ming;  Jiang, Jun 收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022 作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge 收藏  |  浏览/下载：31/0  |  提交时间：2022/05/05 BRCA mutation  China  olaparib  ovarian cancer  PARP inhibitor